RocketTickers

ProQR Announces Positive Interim Results

Long
NASDAQ:PRQR   ProQR Therapeutics N.V.
PRQR: ProQR Therapeutics N.V.
2018-09-05 04:00:00
ProQR Announces Positive Interim Results from Phase 1/2 Clinical Trial of QR-110 in LCA10 Patients, and Plans to Start a Phase 2/3 Pivotal Trial
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.